GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men

Journal of Human Genetics

Volumn 51, Issue 11, 2006, Pages 998-1005

  Vijayalakshmi, Krishnaswamy ^a   Thangaraj, Kumarasamy ^b   Rajender, Singh ^b   Vettriselvi, Venkatesan ^a   Venkatesan, Perumal ^c   Shroff, Sunil ^a   Vishwanathan, K N ^a   Paul, Solomon F D ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^c INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Androgen receptor; CAG repeats; GGN repeats; Haplotypes; Prostate cancer

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; CYTOSINE; GUANOSINE; MICROSATELLITE DNA; REPETITIVE DNA;

ANDROGEN RECEPTOR GENE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RACE DIFFERENCE; RECEPTOR GENE;

AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK; TRINUCLEOTIDE REPEAT EXPANSION; VARIATION (GENETICS);

EID: 33751284705     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-006-0051-z     Document Type: Article

References (26)

1. Chamberlain N, Driver E, Miesfeld R (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 22:3181-3186
2. Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB, Xu J (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 110:122-129
3. Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, Di Tommaso D, Goodman G (2002) Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev 11:1033-1040
4. Cicek MS, Conti DV, Curran A, Phillippa JN, Paris PL, Graham C, John SW (2004) Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate 59:69-76
5. Coetzee GA, Ross RK (1994) Re: prostate cancer and the androgen receptor. J Nat Cancer Inst 86:872-873
6. Correa-Cerro L, Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G, Cussenot O, Kraus P, Just W, Paiss T, Cantu JM, Vogel W(1999) (CAG) n and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 7:357-362
7. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
8. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253
9. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, Dearnaley DP, Eeles RA (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 84:458-465
10. Forrest MS, Edwards SM, Houlston R, Kote Jarai Z, Key T, Allen N, Knowles MA, Turner F, Ardern Jones A, Murkin A, Williams S, Oram R, CR-UK/BPG UK prostate cancer study collaborators et al (2005) Association between hormonal genetic polymorphisms and early onset prostate cancer. Prostate Cancer Prostatic Dis 8:95-102
11. Gao T, Marcelli M, McPhaul MJ (1996) Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 59:9-20
12. Gronberg H (2003) Prostate cancer epidemiology. Lancet 361:859-864
13. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER (1997). Androgen receptor variants with short glutamine or glycine repeats may identify unique sub populations of men with prostate cancer. Clin Cancer Res 3:1599-1608
14. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C (2000) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60:5111-5116
15. Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937-1940
16. Janne OA, Palvimo JJ, Kallio P, Mehto M (1993) Androgen receptor and mechanism of androgen action. Ann Med 25:83-89
17. Jenster G, Ruiter PE, Van der Korput HA, Kuiper GG, Trapman J, Brinkmann AO (1994) Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33:14064-14072
18. Krishnaswamy V, Kumarasamy T, Venkatesan V, Shroff S, Jayanth VR, Paul SFD (2006) South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer. J Hum Genet 51:254-257
19. Lu S, Tsai SY, Tsai MJ (1997) Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI P16 genes. Cancer Res 57:4511-4516
20. Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA (2001) Polymorphic repeats in the androgen receptor gene in highrisk sibships. Prostate 48:200-205
21. Mishra DK, Thangaraj K, Mandhani A, Kumar A, Mittal RD (2005) Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 68:55-60
22. Nwosu V, Carpten J, Trent JM, Sheriden R (2001) Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 10:2313-2318
23. Patrizio P, Leonard DGB, Chen K-L, Hernandez-Ayup S, Trounson AO (2001) Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl 22:444-448
24. Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW (1998) The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomark Prev 7:379-384
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York 9.17-9.19
26. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57:1194-1198